Literature DB >> 8430789

Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes.

P M Catalano1, E D Tyzbir, R R Wolfe, J Calles, N M Roman, S B Amini, E A Sims.   

Abstract

The purpose of this study was to characterize carbohydrate metabolism associated with the development of gestational diabetes. Six control (Ctl) and ten women with gestational diabetes mellitus (GDM) were evaluated using an intravenous glucose tolerance test and hyperinsulinemic-euglycemic clamp with [6,6-2H2]glucose prior to conception (P) and at 12-14 (E), and 34-36 wk of gestation (L). There was an increase (P = 0.0001) in first-phase insulin response in Ctl (P 174 +/- 133, E 388 +/- 120, and L 587 +/- 303 microU/ml) and GDM (P 197 +/- 94, E 267 +/- 77, and L 376 +/- 162 microU/ml) but a significant (P = 0.02) lag in change in GDM with advancing gestation. Basal endogenous glucose production increased during gestation [Ctl: P 2.74 +/- 0.23, E 2.62 +/- 0.38, and L 3.14 +/- 0.36; GDM: P 2.68 +/- 0.51, E 2.78 +/- 0.45, and L 2.98 +/- 0.48 mg.kg fat-free mass (FFM)-1 x min-1; P = 0.02], but there was resistance to suppression by insulin infusion (P = 0.03) in late gestation (GDM: 0.61 +/- 0.44 vs. Ctl: 0.16 +/- 0.17 mg.kg FFM-1 x min-1). Insulin sensitivity decreased during gestation (Ctl: P 10.78 +/- 2.78, E 8.34 +/- 2.36, and L 4.75 +/- 1.22; GDM: P 7.49 +/- 2.13, E 7.40 +/- 1.45, and L 4.21 +/- 1.01 mg.kg FFM-1 x min-1; P = 0.0001) and was primarily decreased (P = 0.04) in GDM compared with Ctl from P through E. These findings closely resemble those of non-insulin-dependent, predominantly insulin-resistant diabetes, which is often a sequel of GDM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430789     DOI: 10.1152/ajpendo.1993.264.1.E60

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  107 in total

Review 1.  Screening for diabetes in pregnancy.

Authors:  S Virjee; S Robinson; D G Johnston
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

2.  Placental growth response to maternal insulin in early pregnancy.

Authors:  Perrie O'Tierney-Ginn; Larraine Presley; Stephen Myers; Patrick Catalano
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

3.  Hepatic and muscle insulin action during late pregnancy in the dog.

Authors:  Cynthia C Connolly; Tracy Papa; Marta S Smith; D Brooks Lacy; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-09-14       Impact factor: 3.619

Review 4.  Gestational diabetes mellitus.

Authors:  Thomas A Buchanan; Anny H Xiang
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum.

Authors:  Linda A Barbour; Carrie E McCurdy; Teri L Hernandez; Jacob E Friedman
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

6.  Glucose turnover and gluconeogenesis in human pregnancy.

Authors:  S Kalhan; K Rossi; L Gruca; E Burkett; A O'Brien
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

7.  Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia.

Authors:  Marcia R Batista; Marta S Smith; Wanda L Snead; Cynthia C Connolly; D Brooks Lacy; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

8.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

Review 9.  Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.

Authors:  Scott M Nelson; Phillippa Matthews; Lucilla Poston
Journal:  Hum Reprod Update       Date:  2009-12-04       Impact factor: 15.610

Review 10.  Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand.

Authors:  P Reddi Rani; Jasmina Begum
Journal:  J Clin Diagn Res       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.